NEUROPACE INC (NPCE) Stock Analyst Ratings

NASDAQ:NPCE • US6412881053

14.45 USD
-1.03 (-6.65%)
At close: Feb 18, 2026
14.45 USD
0 (0%)
After Hours: 2/18/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to NPCE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 19.89. This target is 37.65% above the current price.
  • NPCE was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NPCE.
  • In the previous month the buy percentage consensus was at a similar level.
  • NPCE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
NPCE Historical Analyst RatingsNPCE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 14.4515.1520.4019.8923.10 - 4.84% 41.18% 37.65% 59.86%

Related screens

Find peers 30% below price target
NPCE Current Analyst RatingNPCE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2026-01-27 HC Wainwright & Co. Maintains Buy -> Buy
2025-12-16 UBS Maintains Buy -> Buy
2025-12-10 JP Morgan Maintains Overweight -> Overweight
2025-11-05 Wells Fargo Maintains Overweight -> Overweight
2025-11-05 JP Morgan Maintains Overweight -> Overweight
2025-08-13 Wells Fargo Maintains Overweight -> Overweight
2025-05-28 HC Wainwright & Co. Initiate Buy
2025-05-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-05-14 JP Morgan Maintains Overweight -> Overweight
2025-03-05 Cantor Fitzgerald Maintains Overweight -> Overweight
2025-01-30 Wells Fargo Maintains Overweight -> Overweight
2025-01-21 UBS Initiate Buy
2024-12-17 JP Morgan Maintains Overweight -> Overweight
2024-11-13 Wells Fargo Maintains Overweight -> Overweight
2024-08-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-14 Wells Fargo Maintains Overweight -> Overweight
2024-07-15 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-05-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-14 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-03-12 JP Morgan Maintains Overweight -> Overweight
2024-03-06 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-03-06 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-02-22 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-01-30 Leerink Partners Initiate Outperform
2023-12-27 Lake Street Reiterate Buy -> Buy
2023-12-04 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-14 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-10 Cantor Fitzgerald Initiate Overweight
2023-11-07 JP Morgan Maintains Overweight -> Overweight
2023-10-04 Wells Fargo Maintains Equal-Weight -> Equal-Weight

NEUROPACE INC / NPCE FAQ

Can you provide the average price target for NEUROPACE INC stock?

14 analysts have analysed NPCE and the average price target is 19.89 USD. This implies a price increase of 37.65% is expected in the next year compared to the current price of 14.45.


What is the consensus rating for NPCE stock?

The consensus rating for NEUROPACE INC (NPCE) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.